NASDAQ: NRC - National Research Corporation

Rentabilité sur six mois: -23.85%
Secteur: Healthcare

Calendrier des promotions National Research Corporation


À propos de l'entreprise

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty.

plus de détails
The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, workforce engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

IPO date 1997-10-10
ISIN US6373722023
Industry Health Care Providers & Services
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 2.04
Дивиденд ао 0.24
Сайт https://www.nrchealth.com
Цена ао 31.06
Changement de prix par jour: -2.84% (17.94)
Changement de prix par semaine: +1.51% (17.17)
Changement de prix par mois: -10.52% (19.48)
Changement de prix sur 3 mois: -22.15% (22.39)
Changement de prix sur six mois: -23.85% (22.89)
Changement de prix par an: -55.94% (39.56)
Evolution du prix sur 3 ans: -57.17% (40.7)
Evolution du prix sur 5 ans: -72.68% (63.8)
Evolution des prix sur 10 ans: 0% (17.43)
Evolution des prix depuis le début de l'année: -10.52% (19.48)

Sous-estimation

Nom Signification Grade
P/S 6.63 1
P/BV 20.11 1
P/E 31.79 5
EV/EBITDA 22.12 5
Total: 4.13

Efficacité

Nom Signification Grade
ROA, % 25.3 8
ROE, % 63.26 10
Total: 7.33

Dividendes

Nom Signification Grade
Div yield, % 1.9 4.75
DSI 0.8571 8.57
Total: 5.47

Devoir

Nom Signification Grade
Debt/EBITDA 0.8109 9
Total: 8.4

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 16.08 3
Rentabilité Ebitda, % -4.4 0
Rentabilité EPS, % -0.3763 0
Total: 0.6

Dividende, % Dividende Sur la base des résultats de la période Acheter avant Date de clôture du registre Paiement avant
0.39% 0.12 II кв. 2024 25.09.2024 27.09.2024 14.10.2024
0.3% 0.12 IV кв. 2023 25.03.2024 27.03.2024 11.04.2024
0.29% 0.12 III кв. 2023 26.12.2023 28.12.2023 12.01.2024

Établissements Volume Partager, %
Kayne Anderson Rudnick Investment Management LLC 2881464 12.08
Blackrock Inc. 1065585 4.47
Morgan Stanley 943710 3.96
Vanguard Group Inc 934644 3.92
Conestoga Capital Advisors, LLC 780806 3.27
Dimensional Fund Advisors LP 636402 2.67
QV Investors Inc. 395102 1.66
Renaissance Technologies, LLC 373584 1.57
Geode Capital Management, LLC 356305 1.49
State Street Corporation 342475 1.44

ETF Partager, % Rentabilité pour l'année, % Dividendes, %
iShares MSCI USA Small-Cap Min Vol Factor ETF 0.06502 18.2 1.66828
iShares Russell 2000 Growth ETF 0.02498 38.04 0.6026
iShares Morningstar Small-Cap Growth ETF 0.01365 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.01365 587.89 0.72598
iShares Morningstar Small-Cap ETF 0.00669 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.00669 391.25 1.60498
iShares Russell 3000 ETF 0.00055 24.83 1.43482
SPDR Portfolio Europe ETF 0.00011 8.94 3.66537
Dimensional International Core Equity 2 ETF 0.00006 6.52 3.69996



Superviseur Titre d'emploi Paiement Année de naissance
Mr. Michael D. Hays Founder, CEO, President & Director 131.11k 1955 (70 années)
Ms. Helen L. Hrdy Chief Customer Officer 291.51k 1965 (60 années)
Mr. Jon Boumstein Chief Delivery Officer N/A
Megan Charko Senior Manager of Content Marketing N/A
Mr. Christophe Louvion Chief Product & Technology Officer N/A 1973 (52 année)
Mr. Andy Monnich Chief Corporate Development Officer N/A 1976 (49 années)
Mr. Jason Hahn Chief Revenue Officer N/A 1972 (53 année)
Ms. Linda Stacy Secretary N/A
Ms. Vinitha Ramnathan Chief Product Officer

Adresse: United States, Lincoln. NE, 1245 Q Street - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.nrchealth.com